Codexis Inc (CDXS)
3.49
-0.02
(-0.57%)
USD |
NASDAQ |
Mar 28, 16:00
3.485
0.00 (0.00%)
After-Hours: 20:00
Codexis Cash and Short Term Investments (Quarterly): 65.12M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 65.12M |
September 30, 2023 | 74.58M |
June 30, 2023 | 92.09M |
March 31, 2023 | 102.83M |
December 31, 2022 | 113.98M |
September 30, 2022 | 108.69M |
June 30, 2022 | 90.11M |
March 31, 2022 | 94.26M |
December 31, 2021 | 116.80M |
September 30, 2021 | 119.19M |
June 30, 2021 | 130.80M |
March 31, 2021 | 140.82M |
December 31, 2020 | 150.12M |
September 30, 2020 | 71.52M |
June 30, 2020 | 75.65M |
March 31, 2020 | 87.33M |
December 31, 2019 | 90.50M |
September 30, 2019 | 92.14M |
June 30, 2019 | 93.42M |
March 31, 2019 | 47.32M |
December 31, 2018 | 53.04M |
September 30, 2018 | 54.22M |
June 30, 2018 | 53.62M |
March 31, 2018 | 24.30M |
December 31, 2017 | 31.22M |
Date | Value |
---|---|
September 30, 2017 | 23.83M |
June 30, 2017 | 28.82M |
March 31, 2017 | 13.92M |
December 31, 2016 | 19.24M |
September 30, 2016 | 14.92M |
June 30, 2016 | 22.35M |
March 31, 2016 | 22.16M |
December 31, 2015 | 23.27M |
September 30, 2015 | 16.96M |
June 30, 2015 | 16.60M |
March 31, 2015 | 22.16M |
December 31, 2014 | 26.49M |
September 30, 2014 | 21.52M |
June 30, 2014 | 20.09M |
March 31, 2014 | 24.16M |
December 31, 2013 | 25.14M |
September 30, 2013 | 29.92M |
June 30, 2013 | 37.90M |
March 31, 2013 | 44.18M |
December 31, 2012 | 45.53M |
September 30, 2012 | 50.35M |
June 30, 2012 | 51.36M |
March 31, 2012 | 53.28M |
December 31, 2011 | 53.48M |
September 30, 2011 | 49.64M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
47.32M
Minimum
Mar 2019
150.12M
Maximum
Dec 2020
97.86M
Average
92.78M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
Ampio Pharmaceuticals Inc | 6.398M |
Sutro Biopharma Inc | 375.62M |
Avidity Biosciences Inc | 595.35M |
Taysha Gene Therapies Inc | 143.94M |
Janux Therapeutics Inc | 344.03M |